Poland · Delayed Price · Currency is PLN Hydrapres Statistics
Total Valuation
Hydrapres has a market cap or net worth of PLN 23.40 million. The enterprise value is 36.95 million.
| Market Cap | 23.40M |
| Enterprise Value | 36.95M |
Important Dates
The next confirmed earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hydrapres has 52.93 million shares outstanding. The number of shares has increased by 47.31% in one year.
| Current Share Class | 52.93M |
| Shares Outstanding | 52.93M |
| Shares Change (YoY) | +47.31% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 18.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 2.01.
| Current Ratio | 2.28 |
| Quick Ratio | 1.26 |
| Debt / Equity | 2.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.48 |
| Interest Coverage | -4.80 |
Financial Efficiency
Return on equity (ROE) is -92.00% and return on invested capital (ROIC) is -23.08%.
| Return on Equity (ROE) | -92.00% |
| Return on Assets (ROA) | -10.40% |
| Return on Invested Capital (ROIC) | -23.08% |
| Return on Capital Employed (ROCE) | -21.56% |
| Weighted Average Cost of Capital (WACC) | 5.10% |
| Revenue Per Employee | 334,260 |
| Profits Per Employee | -65,830 |
| Employee Count | 90 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 4.20 |
Taxes
In the past 12 months, Hydrapres has paid 73,313 in taxes.
| Income Tax | 73,313 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.96% in the last 52 weeks. The beta is 0.11, so Hydrapres's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -5.96% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.51 |
| Relative Strength Index (RSI) | 48.42 |
| Average Volume (20 Days) | 1,379 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hydrapres had revenue of PLN 30.08 million and -5.92 million in losses. Loss per share was -0.11.
| Revenue | 30.08M |
| Gross Profit | -106,208 |
| Operating Income | -4.88M |
| Pretax Income | -5.85M |
| Net Income | -5.92M |
| EBITDA | -3.42M |
| EBIT | -4.88M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 1.16 million in cash and 14.71 million in debt, with a net cash position of -13.56 million or -0.26 per share.
| Cash & Cash Equivalents | 1.16M |
| Total Debt | 14.71M |
| Net Cash | -13.56M |
| Net Cash Per Share | -0.26 |
| Equity (Book Value) | 7.30M |
| Book Value Per Share | 0.14 |
| Working Capital | 8.53M |
Cash Flow
In the last 12 months, operating cash flow was -3.52 million and capital expenditures -702,000, giving a free cash flow of -4.23 million.
| Operating Cash Flow | -3.52M |
| Capital Expenditures | -702,000 |
| Depreciation & Amortization | 1.46M |
| Net Borrowing | -3.15M |
| Free Cash Flow | -4.23M |
| FCF Per Share | -0.08 |
Margins
Gross margin is -0.35%, with operating and profit margins of -16.22% and -19.69%.
| Gross Margin | -0.35% |
| Operating Margin | -16.22% |
| Pretax Margin | -19.45% |
| Profit Margin | -19.69% |
| EBITDA Margin | -11.38% |
| EBIT Margin | -16.22% |
| FCF Margin | n/a |
Dividends & Yields
Hydrapres does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.31% |
| Shareholder Yield | -47.31% |
| Earnings Yield | -25.32% |
| FCF Yield | -18.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hydrapres has an Altman Z-Score of 0.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.84 |
| Piotroski F-Score | 2 |